Evidence map›Paper›PMID 39567772›Full record

ArticleCancer gene therapy2025

Correction: SEMA7A-mediated juxtacrine stimulation of IGFBP-3 upregulates IL-17RB at pancreatic cancer invasive front.

Yi-Ing Chen, Sui-Chih Tien, Yi-Ling Ko, Chin-Chun Chang, Min-Fen Hsu, Hung Jen Chien, Hsuan-Yu Peng, Yung-Ming Jeng, Yun-Wen Tien, Yu-Ting Chang and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer gene therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Yi-Ing ChenGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Sui-Chih TienGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Yi-Ling KoGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Chin-Chun ChangGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Min-Fen HsuGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Hung Jen ChienGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Hsuan-Yu PengTMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei, Taiwan.
Yung-Ming JengDepartment of Pathology, National Taiwan University Hospital, Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.ORCID http://orcid.org/0000-0002-9986-7194
Yun-Wen TienDepartment of Surgery, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.ORCID http://orcid.org/0000-0002-9126-2705
Yu-Ting ChangDepartment of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Ming-Chu ChangDepartment of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chun-Mei HuGenomics Research Center, Academia Sinica, Taipei, Taiwan. CMHU1220@gate.sinica.edu.tw.ORCID http://orcid.org/0000-0002-4248-0896

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39567772
PMCPMC11772229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.